Apitope International NV, which is developing peptide therapies for autoimmune diseases, has appointed Hayley French as its commercial director. Dr French, who has a PhD in microbiology and an MSc in intellectual property from the University of London, joins Apitope’s management team with a remit to maximise the potential of the company’s technology platform. Prior to joining Apitope, Dr French spent three years at Novartis where she working closely on deals and collaborations in the respiratory division. Before that, she worked in the life sciences group at Bird & Bird in London.
Copyright 2010 Evernow Publishing Ltd